Position in OGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$677,000
+$365,820 QoQ
Shares Held
50,000
-3.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#169
of 625 holders
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Sep 30, 2025CallValue
$475,260
CallShares
44,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $358,862,750 across 12 Drug Manufacturers - General names. OGN ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
239,779 | $86,828,771 | |
| 2 | ABBV |
AbbVie Inc.
|
268,264 | $67,505,952 | |
| 3 | MRK |
Merck & Co., Inc.
|
362,956 | $46,639,846 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
345,805 | $43,689,003 | |
| 5 | AZN |
Astrazeneca PLC
|
186,676 | $35,397,503 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
508,740 | $29,313,598 | |
| 7 | JNJ |
Johnson & Johnson
|
68,010 | $17,272,499 | |
| 8 | PFE |
Pfizer Inc
|
642,123 | $15,462,321 |
All Filings in OGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $677,000 | 50,000 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $311,180 | 51,950 | Shares | Defined | 2026-05-08 | |
| 2025-09-30 | $475,260 | 44,500 | Call | Defined | 2025-11-13 | |
| 2023-06-30 | $2,081,000 | 100,000 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $1,955,100 | 70,000 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||